JS
Insider
Jereme M Sylvain
EVP, Chief Financal OfficerJereme M Sylvain (EVP, Chief Financal Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in DexCom, Inc. (DXCM). The largest single filing was $303K of DXCM (3,638 sh × $83.27, as filed), executed Sep 10.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$303K
shares × price, as filed
Last traded
Sep 10
Filed Sep 14
Median ADV $483.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
DXCMRecent filings
DXCMSALE
DexCom, Inc.
View filing →
$303K3,638 sh × $83.27
Exec Sep 10
Filed Sep 14 · 4:02 PM ET DXCMSALE DexCom, Inc. View filing → $358K
4,824 sh × $74.17
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET DXCMSALE DexCom, Inc. View filing → $845K
12,001 sh × $70.38
Exec Mar 12 2025
Filed Mar 14 2025 · 5:30 PM ET DXCMSALE DexCom, Inc. View filing → $433K
5,873 sh across 2 lots
Exec Mar 10 2025
Filed Mar 11 2025 · 5:30 PM ET DXCMSALE DexCom, Inc. View filing → $182K
2,090 sh × $86.91
Exec Jan 29 2025
Filed Jan 30 2025 · 5:30 PM ET DXCMSALE DexCom, Inc. View filing → $264K
3,500 sh × $75.51
Exec Nov 15 2024
Filed Nov 18 2024 · 5:30 PM ET